Search research articles
Contact Us
Filters
Showing results (91-100 of 98) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 98 results.
Scientific Reports
|
November 6, 2014
Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients
Annamaria Ruzzo, Francesco Graziano, Fabio Galli, et al.
Cancers
|
October 14, 2023
Neoadjuvant Systemic Therapy in Early Breast Cancer: Results of a Prospective Observational Multicenter BRIDE Study
Stefania Gori, Alessandra Fabi, Catia Angiolini, et al.
Journal of Gynecologic Oncology
|
July 1, 2025
Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of the AtTEnd/ENGOT-EN7 trial
Kenichi Harano, Roldano Fossati, Beatriz Pardo, et al.
Therapeutic Advances in Medical Oncology
|
February 4, 2020
Khorana score and thromboembolic risk in stage II-III colorectal cancer patients: a <i>post hoc</i> analysis from the adjuvant TOSCA trial
Sandro Barni, Gerardo Rosati, Sara Lonardi, et al.
The Lancet. Oncology
|
August 5, 2024
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial
Nicoletta Colombo, Elena Biagioli, Kenichi Harano, et al.
The Lancet. Rheumatology
|
November 1, 2024
Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases framework
Emanuel Della-Torre, Rosaria Talarico, Jose Ballarin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 24, 2023
STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines
Claudia Proto, Sara Manglaviti, Giuseppe Lo Russo, et al.
The Oncologist
|
January 5, 2019
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis
Claudio Vernieri, Fabio Galli, Laura Ferrari, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 98) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 98 results.
Scientific Reports
|
November 6, 2014
Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients
Annamaria Ruzzo, Francesco Graziano, Fabio Galli, et al.
Cancers
|
October 14, 2023
Neoadjuvant Systemic Therapy in Early Breast Cancer: Results of a Prospective Observational Multicenter BRIDE Study
Stefania Gori, Alessandra Fabi, Catia Angiolini, et al.
Journal of Gynecologic Oncology
|
July 1, 2025
Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of the AtTEnd/ENGOT-EN7 trial
Kenichi Harano, Roldano Fossati, Beatriz Pardo, et al.
Therapeutic Advances in Medical Oncology
|
February 4, 2020
Khorana score and thromboembolic risk in stage II-III colorectal cancer patients: a <i>post hoc</i> analysis from the adjuvant TOSCA trial
Sandro Barni, Gerardo Rosati, Sara Lonardi, et al.
The Lancet. Oncology
|
August 5, 2024
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial
Nicoletta Colombo, Elena Biagioli, Kenichi Harano, et al.
The Lancet. Rheumatology
|
November 1, 2024
Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases framework
Emanuel Della-Torre, Rosaria Talarico, Jose Ballarin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 24, 2023
STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines
Claudia Proto, Sara Manglaviti, Giuseppe Lo Russo, et al.
The Oncologist
|
January 5, 2019
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis
Claudio Vernieri, Fabio Galli, Laura Ferrari, et al.
Page
of 10